Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Mylan vs Durogesic DTrans fentanyl transdermal systems (25 µg/h) under naltrexone block
2005-002935-28Phase 2Completed
- Sponsor
- Bertek Pharmaceuticals International
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Durogesic D-TRANS in chronic pain (2 arms), sponsored by Bertek Pharmaceuticals International. Primary endpoint: Pharmacokinetic bioequivalence. Started Jul 2005; status: completed.
02
Drugs
Durogesic D-TRANS
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2005-002935-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002935-28.